News
2/28/2008Nimbus changes name to Sovicell and launches new website
2/20/2008Sovicell announces winner of the iPod raffle
1/25/2008Presentation of first validation data for the TRANSIL blood-to-brain absorption kit at the predictive human toxicity/ADME-Tox meeting in Brussels
9/1/2007Release of TRANSIL Blood-to-Brain absorption kit
About Sovicell
Investor Relations
Apart from the management team shareholders in SOVICELL include:
- MIG AG & CO KG Investment fund I,

- Sachsen LB group,

- Wellington Partners GmbH,

- German Austrian Beteiligungs GmbH & CO KG
- Global Asset Fund GmbH & CO KG.
For further information on investment opportunities at Sovicell, please contact Sven Rüger, CFO.